Announcements Trials

Browse Landscape

Phase

Phase 2 26 Phase 1 19 Phase 1/2 14 Phase NA 3 Phase 3 2 Phase 4 1

Status

Sponsor Class

OTHER_GOV 1 OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Dexamethasone 49 Metformin 47 Cyclophosphamide 42 Saline Solution 38 Cytarabine 34 Sodium Chloride 32 Bupivacaine 31 Vincristine 27 Cisplatin 26 Propofol 25 Methotrexate 25 Letrozole 24 Fluorouracil 24 Dexmedetomidine 24 Doxorubicin 23 Fentanyl 22 Carboplatin 22 Etoposide 19 Rituximab 18 Morphine 18 Bevacizumab 18 Acetaminophen 18 Lidocaine 17 Granulocyte Colony-Stimulating Factor 17 Prednisone 16 Mercaptopurine 16 Docetaxel 16 Clomiphene 16 Sevoflurane 15 Ropivacaine 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × OTHER × plerixafor × Clear all

NCT05510544 2023-03-13

Plerixafor for Poorly Mobilized Lymphoma

Peking University

Phase 4 Unknown

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡